Sponsors
Wilson Sonsini

Who's Online
We have 4 guests online
Stephen Schneider

Most recently, from November 2004 to mid-January 2006, Stephen served as President and CEO of EnviroSystems, Inc. (ESI) where he continues as a Director.  ESI invented and commercialized a nano-emulsion-formulated, non-toxic, broad spectrum disinfectant that kills 21+ pathogens (including HIV, TB, Hep B&C, SARS simulant, Influenza A) without harming humans, animals or the environment.  After serving as mentor to the prior CEO during the 2004 Springboard process and subsequent Stanford event, the ESI board asked Stephen to assume command in order to refinance and turn the company around.  In 3 1/2 months, starting with only $5K in cash, Stephen re-positioned the company taking it public in January 2006 through a reverse triangular merger with an $8.5MM PIPE offering that retained 40% ownership in the surviving company in favor of the ESI Preferred holders.

Prior to turning ESI around, Stephen founded Molecular Delivery Corporation (MDC) in 1998 and ran it as CEO through conception, initial development and patenting of novel technology which enables systemic administration, through the lungs, of a wide range of pure pharmaceutical compounds in their vapor states.  In summer 2001, MDC successfully completed a proof of concept study in dogs with pharmacokinetics identical to IV administration.  In mid-December 2001 Stephen then merged MDC with Alexza, a company founded in 2000 by Alex Zaffaroni, to form Alexza Molecular Delivery Corporation (Alexza MDC, now known as Alexza Pharmaceuticals, Inc.) securing an additional $9M Series B investment from Alex.  Stephen ran Alexza MDC as President and COO until mid-2003, but remained on the board until December 2005 when he retired upon the filing of the company’s S-1 announcing its intended IPO.  Prior to MDC, from 1985 to 1989, Stephen served as Director of Corporate Development (Marketing and Sales) at Corus Medical Corporation, a start-up company which stored autologous blood for patients anticipating transfusions.

Stephen holds a J.D. from Golden Gate University School of Law in San Francisco, CA, an M.A. in Behavioral Sciences (Organizational Development and Counseling Psychology) from The University of Houston, Clear Lake, TX, and a B.A. in Fine Arts with a minor in Pre-Medical Studies from Earlham College, Richmond, IN.  Stephen is a native of Galveston, TX and currently lives with his wife and son in Palo Alto, California.